Phacilitate Leaders Forum

Phacilitate Leaders Europe Agenda 2018


Chair's introduction

Manufacturing Scalability - Cell & Gene Therapy Europe

Opening question: Making the business case: is now the time to invest in automation?


What are your stories from the past year?
Qasim Rafiq, Senior Lecturer in Bioprocessing of Regenerative, Cellular & Gene Therapy - University College London
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd